2026 Interim Award Funding Policy

The Department of Health and Human Services (HHS), including National Institutes of Health (NIH), operates under the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) signed by President Trump on November 12, 2025. This Act (CR) continues government operations through January 30, 2026, at the Fiscal Year (FY) 2025 enacted level, with no reduction. NIDDK extramural research is organized into 3 programmatic divisions: 1) Diabetes, Endocrinology, and Metabolic Diseases; 2) Digestive Diseases and Nutrition; and 3) Kidney, Urologic, and Hematologic Diseases.

Consistent with NIH practices during the CRs of FYs 2006 - 2025, NIH Institutes and/or Centers may, at their discretion, issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award. All legislative mandates that were in effect in FY 2025 (see NOT-OD-24-110) remain in effect under this CR, as well as the salary limitation set at Executive Level II of the Federal Pay Scale (see NOT-OD-25-085) and the Ruth L. Kirschstein National Research Service Award predoctoral and postdoctoral stipend levels and tuition/fees as described in NOT-OD-25-105.

See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-26-011.html for details.

• NIDDK will announce additional details regarding its interim FY 2026 funding policy, including details regarding funding of competing grant applications as information becomes available.